Viral load predicts new world health organization stage 3 and 4 events in HIV-infected children receiving highly active antiretroviral therapy, independent of CD4 T lymphocyte value.
Oliveira
Ricardo
R
Instituto de Puericultura e Pediatria Martagão Gesteira, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brasil.
Krauss
Margot
M
Essama-Bibi
Suzanne
S
Hofer
Cristina
C
Robert Harris
D
D
Tiraboschi
Adriana
A
de Souza
Ricardo
R
Marques
Heloisa
H
Succi
Regina
R
Abreu
Thalita
T
Della Negra
Marinella
M
Hazra
Rohan
R
Mofenson
Lynne M
LM
Siberry
George K
GK
D000293:Adolescent; D019380:Anti-HIV Agents / Q000627:therapeutic use*; D023241:Antiretroviral Therapy, Highly Active / Q000379:methods*; D018791:CD4 Lymphocyte Count; D002648:Child; D002675:Child, Preschool; D016903:Drug Monitoring; D005260:Female; D015658:HIV Infections / Q000188:drug therapy* / Q000276:immunology / Q000473:pathology / Q000821:virology*; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007843:Latin America; D008297:Male; D012720:Severity of Illness Index; D017211:Treatment Failure; D019562:Viral Load
D019380:Anti-HIV Agents